𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation

✍ Scribed by P.L. L’Allier; A. Ducharme; P.F. Keller; H. Yu; M.C. Guertin; J.C. Tardif

Book ID
113414464
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
48 KB
Volume
13
Category
Article
ISSN
1062-1458

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metabolic effects of long-term angiotens
Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition
✍ R. Reneland; P.-E. Andersson; A. Haenni; H. Lithell 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 566 KB

Fifty patients with mild to moderate essential hypertension were randomized to receive either 20 mg fosinopril daily for 16 weeks or placebo for 4 weeks followed by 12 weeks of 50 mg atenolol daily. Prior to these 16 weeks there was a placebo wash-out period of 2-6 weeks. Blood pressure measurements